Twist Bioscience Corporation
TWST · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $376,572 | $312,974 | $245,109 | $203,565 |
| % Growth | 20.3% | 27.7% | 20.4% | – |
| Cost of Goods Sold | $185,570 | $179,625 | $155,380 | $119,330 |
| Gross Profit | $191,002 | $133,349 | $89,729 | $84,235 |
| % Margin | 50.7% | 42.6% | 36.6% | 41.4% |
| R&D Expenses | $80,285 | $90,852 | $106,894 | $120,307 |
| G&A Expenses | $239,976 | $0 | $186,838 | $0 |
| SG&A Expenses | $246,976 | $218,398 | $189,738 | $212,949 |
| Sales & Mktg Exp. | $7,000 | $0 | $2,900 | $0 |
| Other Operating Expenses | $0 | $44,930 | $10,256 | -$14,245 |
| Operating Expenses | $327,261 | $354,180 | $306,888 | $319,011 |
| Operating Income | -$136,259 | -$220,831 | -$217,159 | -$234,776 |
| % Margin | -36.2% | -70.6% | -88.6% | -115.3% |
| Other Income/Exp. Net | $59,308 | $12,665 | $13,693 | $6,502 |
| Pre-Tax Income | -$76,951 | -$208,166 | -$203,466 | -$228,274 |
| Tax Expense | $719 | $560 | $1,152 | -$10,411 |
| Net Income | -$77,670 | -$208,726 | -$204,618 | -$217,863 |
| % Margin | -20.6% | -66.7% | -83.5% | -107% |
| EPS | -1.3 | -3.6 | -3.6 | -4.04 |
| % Growth | 63.9% | 0% | 10.9% | – |
| EPS Diluted | -1.3 | -3.6 | -3.6 | -4.04 |
| Weighted Avg Shares Out | 59,808 | 58,016 | 56,885 | 53,885 |
| Weighted Avg Shares Out Dil | 59,808 | 58,016 | 56,885 | 53,885 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11,364 | $15,344 | $14,365 | $3,062 |
| Interest Expense | $0 | $29 | $5 | $80 |
| Depreciation & Amortization | $24,853 | $31,432 | $29,310 | $16,514 |
| EBITDA | -$52,098 | -$176,705 | -$174,151 | -$211,680 |
| % Margin | -13.8% | -56.5% | -71.1% | -104% |